Model‐based prediction of effective target exposure for <scp>MEN1611</scp> in combination with trastuzumab in <scp>HER2</scp>‐positive advanced or metastatic breast cancer patients
2023 · CPT Pharmacometrics & Systems Pharmacology · 14 citations
https://doi.org/10.1002/psp4.12910